Market research
Evidence-led reporting across United States and Australian markets.
3 results
Australia · Company Research
Mesoblast (ASX:MSB) shares closed 23.4% higher at A$2.32 on Thursday 29 October 2026, the best performance in the ASX 200, according to IBTimes. The cell therapy company’s quarterly…
Australia · Company Research
Mesoblast shares closed at A$1.77 on Monday 19 October 2026, about 11% below the A$1.99 they traded at before the company’s September quarter update. Sales of its approved…
Australia · Company Research
The Mesoblast (ASX: MSB) share price rose 6.67% on Friday, 10 July 2026, gaining 14 cents to close at A$2.24. The stock also gained approximately 9.3% across the…
